PUBLIC DISPLAY OF APPLICATION DOSSIER FOR CONFINED FIELD TRIAL OF CASSAVA GENETICALLY MODIFIED FOR REDUCTION IN STARCH BREAKDOWN IN STORAGE ROOTS.
In accordance with the National Biosafety Management Agency Act, 2015, requiring the public display of any Biosafety application, for a permit to intentionally release genetically modified organisms (GMOs), for comments, the National Biosafety Management Agency (NBMA) hereby announces a twenty-one (21) working day display of an application dossier for the confined field trial (CFT) of genetically modified cassava. The display, with effect from 27th July 2017 to 24th August 2017, is to enable the public to make input that would facilitate informed decisions on the application.
Description of the proposed CFT
The confined field trial is for the purpose of:
The construct transgenic AMY3 RNAi is having a phytozome gene driven by Solanum tuberosum patatin promoter that confers silencing to storage tissues which will reduce starch breakdown in the root organs.
Display Centers are:
Date: 27th July, 2017 – 24th August, 2017
Time: 8:00am – 4:00 pm
All comments should be forwarded to the office of the Director-General/ Chief Executive Officer, National Biosafety Management Agency, National Park Services, Umaru Musa Yar' Adua Expressway, Airport Road, Abuja.
Director-General/Chief Executive Officer